Table 3 Funding requirements for the surveillance for substandard and falsified medicines in the reporting period (Jan. 2019–Dec. 2020).

From: Surveillance for substandard and falsified medicines by local faith-based organizations in 13 low- and middle-income countries using the GPHF Minilab

External funding:

14,300 €

Consumables for GPHF Minilab analysis:

41.7% for solvents (procured locally); 32.9% for reference standards and 19.7% for TLC plates, glassware and GPHF Minilab manuals (procured and shipped through TTM Technologie Transfer Marburg e.V.; Coelbe, Germany); 5.6% for packaging and shipment

10,500 €

17 confirmatory compendial analyses at MEDS laboratory, Nairobi (offered at reduced rates)

2,000 €

GPHF Minilab training course in Rwanda

22,800 €

Personnel costs for research pharmacist/network coordinator at Difäm, Tuebingen, Germany (0.2 full-time equivalents)

 = 49,600 €

Total external funding (47,600 € from Bread for the World, Berlin, Germany; 2,000 € from Difäm, Tübingen, Germany)

Contributions by network participants

Staff time for GPHF Minilab analyses and documentation by 16 participating drug supply organizations

Acquisition costs of medicine samples by 16 participating drug supply organizations

Purchase of one GPHF Minilab (5,500 €) by one participating drug supply organization, using its own funds

8 confirmatory compendial analyses at Tuebingen University laboratory, Germany, provided at no charge

Back to article page